Cluster headache in adults.
Jason Charles RayRichard J StarkElspeth Jane HuttonPublished in: Australian prescriber (2022)
Cluster headache is characterised by attacks of very severe, unilateral headache lasting 15-180 minutes, up to eight times per day. The attacks are associated with cranial autonomic symptoms on the same side and a sense of agitation or restlessness First-line acute abortive treatments include intranasal or subcutaneous sumatriptan or high-flow oxygen. Neuromodulation may benefit some patients First-line preventive therapy is high-dose verapamil. Close monitoring is required for the adverse effect of arrhythmia There are several emerging therapies that have either proven efficacy, or possible benefit for cluster headache. They include drugs aimed at the calcitonin gene-related peptide.
Keyphrases
- high dose
- end stage renal disease
- ejection fraction
- drug induced
- newly diagnosed
- chronic kidney disease
- low dose
- prognostic factors
- liver failure
- peritoneal dialysis
- emergency department
- stem cells
- early onset
- heart rate variability
- intensive care unit
- bone marrow
- stem cell transplantation
- mesenchymal stem cells
- hepatitis b virus
- patient reported outcomes
- blood pressure
- transcription factor
- atrial fibrillation
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- aortic dissection
- cell therapy